Sinocelltech Group Limited (SHA:688520)

China flag China · Delayed Price · Currency is CNY
40.18
-0.68 (-1.66%)
May 22, 2025, 2:45 PM CST
-12.44%
Market Cap 18.20B
Revenue (ttm) 2.42B
Net Income (ttm) 101.52M
Shares Out 445.34M
EPS (ttm) 0.21
PE Ratio 193.18
Forward PE 34.05
Dividend n/a
Ex-Dividend Date n/a
Volume 5,056,422
Average Volume 3,007,435
Open 40.55
Previous Close 40.86
Day's Range 40.02 - 40.98
52-Week Range 31.07 - 49.52
Beta 0.60
RSI 60.83
Earnings Date Apr 26, 2025

About Sinocelltech Group

Sinocelltech Group Limited, a biotech company, engages in the research and development, and industrialization of recombinant proteins, monoclonal antibodies, and innovative vaccines in China. The company offers Anpingxi an antibody drug and anti-tumor product; Anjiayin for the treatment of the rare disease hemophilia A; coronavirus 2-valent, a trimer protein vaccine; and mutant strain recombinant protein vaccines SCTV01C and SCTV01E. Its pipeline products include SCT630 used for the treatment of autoimmune diseases; SCT510 for the treatment of ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,313
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.